Jose L. Vazquez-Gomez
L'hospitalet De Llobregat, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Avidity of autoantibodies against type I interferons as a factor associated with neurological complications in severe COVID-19.
Journal: Frontiers in immunology
Published: May 28, 2026
Prevalence and functional characterization of anti-interferon autoantibodies in inflammatory myopathies.
Journal: Rheumatology (Oxford, England)
Published: April 24, 2025
Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients.
Journal: Clinical immunology (Orlando, Fla.)
Published: February 26, 2025
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 Severity.
Journal: Journal of clinical immunology
Published: February 21, 2025
Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients.
Journal: Frontiers in immunology
Published: January 07, 2025
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination.
Journal: Cell communication and signaling : CCS
Published: December 04, 2023
Kisspeptins and norepinephrine regulate different G-protein-coupled receptor signaling pathways.
Journal: Translational lung cancer research
Published: June 30, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026